GlassScriptPhysician profile
Russell J Cornell
NPI 1285639088
$1,226.82
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $497 · 2022: $17.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $230.80 | 2019-2020 | |
| Abbott Laboratories | $145.78 | 2019-2020 | |
| Boston Scientific Corporation | $134.19 | 2019 | |
| Pfizer INC. | $131.54 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $126.47 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $78.03 | 2019-2020 | |
| Amgen INC. | $55.01 | 2019 | |
| Amarin Pharma, INC. | $44.75 | 2019-2020 | |
| Biosense Webster, INC. | $30.20 | 2020 | |
| Esperion Therapeutics, INC. | $28.76 | 2020 | |
| Arbor Pharmaceuticals, INC. | $20.44 | 2019 | |
| Daiichi Sankyo INC. | $20.40 | 2020 | |
| Philips North America LLC | $17.18 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.70 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $14.52 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.46 | 2019 | |
| Astellas Pharma US INC | $12.80 | 2019 | |
| Gilead Sciences, INC. | $11.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Cornell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.